Clinical Trials
22 trialsNCT03114462 2026-04-15
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT07145177 2026-03-23
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
University of California, San Francisco
Phase 1 Recruiting
NCT07340853 2026-03-10
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
University of California, San Francisco
Phase 1 Recruiting
NCT00515372 2026-03-09
Depression Treatment and Screening in Ovarian Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT07353229 2026-01-23
68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma
Thomas Jefferson University
Phase 1 Suspended
NCT02199236 2024-11-01
Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02048150 2023-03-21
Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer
City of Hope Medical Center
Phase 1 Completed
NCT02572284 2023-01-19
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02095054 2021-04-01
Regorafenib and Cetuximab in Patients With Advanced Malignancy
M.D. Anderson Cancer Center
Phase 1 Completed
NCT02948283 2021-02-12
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT02225574 2020-02-12
An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT02530047 2019-07-18
Mesenchymal Stem Cells (MSC) for Ovarian Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT03481127 2019-06-03
Psychological Services Integration in Gynecological Oncology Clinics
Washington University School of Medicine
Phase 1 Completed
NCT01440582 2019-03-04
Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients
M.D. Anderson Cancer Center
Phase 1 Completed
NCT03106610 2018-05-24
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01200316 2017-11-30
Rocking Motion: Physiologic Effect on the Surgical Stress Response
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00513097 2017-11-06
Curbing Tobacco Use in Suburban and Rural Schools
M.D. Anderson Cancer Center
Phase 1 Completed
NCT02251639 2017-04-27
Diagnostic Aids for Detection and Diagnosis of Oral Cancer
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT01807286 2016-05-13
Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01036412 2016-02-19
Chlorhexidine Gel Therapy for Cariogenic Oral Microflora
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01562301 2015-06-08
Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT00506064 2012-12-05
Melatonin Postoperative Sleep Study in Breast Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Terminated